OBJECTIVES: There is increasing evidence that bisphosphonates affect orthodontic tooth movement. The object of the study was to investigate the changes produced by tensile strain on human periodontal ligament fibroblasts (HPdLFs) treated with clodronate or zoledronate. MATERIALS AND METHODS: HPdLF were cultured with 5 and 50 μM clodronate or zoledronate for 48 h and applied to tensile strain (TS) (5 and 10 %) for 12 h in vitro. Viability was verified by MTT assay and apoptosis rate via caspase 3/7 assay. Gene expression of receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG) was investigated using real-time PCR. OPG was also analyzed by ELISA and RANKL by immunocytochemical staining. RESULTS: Zoledronate (50 μM) reduced the viability of HPdLF (76 vs 100 %) and combined with 5 % TS to 53 %. TS of 10 % and clodronate reduced viability to 79 % with increased caspase 3/7 activity. Clodronate (5 μM) led to a slight increase of OPG gene expression, zoledronate (5 μM) to a slight decrease. Combined with 5 % TS, both increased OPG gene expression (2-3-fold) and OPG synthesis. Zoledronate increased gene expression of RANKL (4-fold). Combined with 5 % of TS, this increase was abolished. TS of 10 % in combination amplified increase of RANKL ending up with a 9-fold gene expression by clodronate and high RANKL protein synthesis. CONCLUSIONS: This study shows for the first time that mechanical loading alters the effects of bisphosphonates on viability, apoptosis rate, and OPG/RANKL system of HPdLF dependent on the applied strength. Low forces and bisphosphonates increase factors for bone apposition, whereas high forces combined with bisphosphonates stimulate osteoclastogenesis. CLINICAL RELEVANCE: Mechanical loading of periodontal ligament with high strengths should be avoided during bisphosphonate therapy.
OBJECTIVES: There is increasing evidence that bisphosphonates affect orthodontic tooth movement. The object of the study was to investigate the changes produced by tensile strain on human periodontal ligament fibroblasts (HPdLFs) treated with clodronate or zoledronate. MATERIALS AND METHODS: HPdLF were cultured with 5 and 50 μM clodronate or zoledronate for 48 h and applied to tensile strain (TS) (5 and 10 %) for 12 h in vitro. Viability was verified by MTT assay and apoptosis rate via caspase 3/7 assay. Gene expression of receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG) was investigated using real-time PCR. OPG was also analyzed by ELISA and RANKL by immunocytochemical staining. RESULTS:Zoledronate (50 μM) reduced the viability of HPdLF (76 vs 100 %) and combined with 5 % TS to 53 %. TS of 10 % and clodronate reduced viability to 79 % with increased caspase 3/7 activity. Clodronate (5 μM) led to a slight increase of OPG gene expression, zoledronate (5 μM) to a slight decrease. Combined with 5 % TS, both increased OPG gene expression (2-3-fold) and OPG synthesis. Zoledronate increased gene expression of RANKL (4-fold). Combined with 5 % of TS, this increase was abolished. TS of 10 % in combination amplified increase of RANKL ending up with a 9-fold gene expression by clodronate and high RANKL protein synthesis. CONCLUSIONS: This study shows for the first time that mechanical loading alters the effects of bisphosphonates on viability, apoptosis rate, and OPG/RANKL system of HPdLF dependent on the applied strength. Low forces and bisphosphonates increase factors for bone apposition, whereas high forces combined with bisphosphonates stimulate osteoclastogenesis. CLINICAL RELEVANCE: Mechanical loading of periodontal ligament with high strengths should be avoided during bisphosphonate therapy.
Authors: Andreas M Pabst; Thomas Ziebart; Felix P Koch; Katherine Y Taylor; Bilal Al-Nawas; Christian Walter Journal: Clin Oral Investig Date: 2011-01-12 Impact factor: 3.573
Authors: Neelambar R Kaipatur; Yuchin Wu; Samer Adeeb; Thomas R Stevenson; Paul W Major; Michael R Doschak Journal: Am J Orthod Dentofacial Orthop Date: 2013-10 Impact factor: 2.650
Authors: Felix Peter Koch; Christina Merkel; Thomas Ziebart; Ralf Smeets; Christian Walter; Bilal Al-Nawas Journal: Clin Oral Investig Date: 2010-10-12 Impact factor: 3.573
Authors: Felix P Koch; Annette Wunsch; Christina Merkel; Thomas Ziebart; Andreas Pabst; Sareh Said Yekta; Marco Blessmann; Ralf Smeets Journal: Head Face Med Date: 2011-02-07 Impact factor: 2.151
Authors: Sarah Grimm; Eva Wolff; Christian Walter; Andreas M Pabst; Ambili Mundethu; Cornelius Jacobs; Heiner Wehrbein; Collin Jacobs Journal: Clin Oral Investig Date: 2019-05-17 Impact factor: 3.573
Authors: L Nettelhoff; S Grimm; C Jacobs; C Walter; A M Pabst; J Goldschmitt; H Wehrbein Journal: Clin Oral Investig Date: 2015-08-06 Impact factor: 3.573
Authors: Anna Di Vito; E Chiarella; F Baudi; P Scardamaglia; A Antonelli; D Giudice; T Barni; L Fortunato; A Giudice Journal: Cell Transplant Date: 2020 Jan-Dec Impact factor: 4.064